div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries Sites with intimal thickness mm were defined as atherosclerotic A total of sites within 1477 segments in 574 src=https:reader033fdocumentsnetreader033viewer20220415075e2611993e4346564d223bc8html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries Sites with intimal thickness mm were defined as atherosclerotic A total of sites within 1477 segments in 574 src=https:reader033fdocumentsnetreader033viewer20220415075e2611993e4346564d223bc8html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries Sites with intimal thickness mm were defined as atherosclerotic A total of sites within 1477 segments in 574 src=https:reader033fdocumentsnetreader033viewer20220415075e2611993e4346564d223bc8html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries Sites with intimal thickness mm were defined as atherosclerotic A total of sites within 1477 segments in 574 src=https:reader033fdocumentsnetreader033viewer20220415075e2611993e4346564d223bc8html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: ASCVD Risk Reduction Therapy: Beyond Statinsmultiple coronary arteries Sites with intimal thickness mm were defined as atherosclerotic A total of sites within 1477...